These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 35774790)

  • 21. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.
    Ahn E; Youngblood B; Lee J; Lee J; Sarkar S; Ahmed R
    J Virol; 2016 Oct; 90(19):8934-46. PubMed ID: 27466420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8
    Wang K; Coutifaris P; Brocks D; Wang G; Azar T; Solis S; Nandi A; Anderson S; Han N; Manne S; Kiner E; Sachar C; Lucas M; George S; Yan PK; Kier MW; Laughlin AI; Kothari S; Giles J; Mathew D; Ghinnagow R; Alanio C; Flowers A; Xu W; Tenney DJ; Xu X; Amaravadi RK; Karakousis GC; Schuchter LM; Buggert M; Oldridge D; Minn AJ; Blank C; Weber JS; Mitchell TC; Farwell MD; Herati RS; Huang AC
    Cancer Cell; 2024 Sep; 42(9):1582-1597.e10. PubMed ID: 39214097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
    Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
    Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
    Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of PD-1 during effector CD8 T cell differentiation.
    Ahn E; Araki K; Hashimoto M; Li W; Riley JL; Cheung J; Sharpe AH; Freeman GJ; Irving BA; Ahmed R
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4749-4754. PubMed ID: 29654146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection.
    Ferrando-Martinez S; Snell Bennett A; Lino E; Gehring AJ; Feld J; Janssen HLA; Robbins SH
    Front Immunol; 2021; 12():648420. PubMed ID: 34589081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.
    Alfei F; Kanev K; Hofmann M; Wu M; Ghoneim HE; Roelli P; Utzschneider DT; von Hoesslin M; Cullen JG; Fan Y; Eisenberg V; Wohlleber D; Steiger K; Merkler D; Delorenzi M; Knolle PA; Cohen CJ; Thimme R; Youngblood B; Zehn D
    Nature; 2019 Jul; 571(7764):265-269. PubMed ID: 31207605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
    Jin HT; Anderson AC; Tan WG; West EE; Ha SJ; Araki K; Freeman GJ; Kuchroo VK; Ahmed R
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14733-8. PubMed ID: 20679213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-Intrinsic CD38 Expression Sustains Exhausted CD8
    DeRogatis JM; Neubert EN; Viramontes KM; Henriquez ML; Nicholas DA; Tinoco R
    J Virol; 2023 Apr; 97(4):e0022523. PubMed ID: 37039663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis.
    Casella V; Cebollada Rica P; Argilaguet J; Vidal E; González-Cao M; Güerri-Fernandez R; Bocharov G; Meyerhans A
    Viruses; 2024 May; 16(5):. PubMed ID: 38793680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TOX-expressing terminally exhausted tumor-infiltrating CD8
    Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
    Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic CD4
    Snell LM; Xu W; Abd-Rabbo D; Boukhaled G; Guo M; Macleod BL; Elsaesser HJ; Hezaveh K; Alsahafi N; Lukhele S; Nejat S; Prabhakaran R; Epelman S; McGaha TL; Brooks DG
    Nat Immunol; 2021 Dec; 22(12):1524-1537. PubMed ID: 34795443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8
    Rezazadeh H; Astaneh M; Tehrani M; Hossein-Nataj H; Zaboli E; Shekarriz R; Asgarian-Omran H
    Immunol Res; 2020 Oct; 68(5):269-279. PubMed ID: 32710227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection.
    Gabriel SS; Tsui C; Chisanga D; Weber F; Llano-León M; Gubser PM; Bartholin L; Souza-Fonseca-Guimaraes F; Huntington ND; Shi W; Utzschneider DT; Kallies A
    Immunity; 2021 Aug; 54(8):1698-1714.e5. PubMed ID: 34233154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional restoration of exhausted CD4(+) and CD8(+) T cells in chronic viral infection by vinegar-processed flos of Daphne genkwa.
    Uyangaa E; Choi JY; Patil AM; Kim JH; Kim SB; Kim K; Ryu HW; Oh SR; Eo SK
    Comp Immunol Microbiol Infect Dis; 2015 Apr; 39():25-37. PubMed ID: 25744061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model.
    He R; Yang X; Liu C; Chen X; Wang L; Xiao M; Ye J; Wu Y; Ye L
    Cell Mol Immunol; 2018 Sep; 15(9):815-826. PubMed ID: 28287115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a T-bet
    Raju S; Xia Y; Daniel B; Yost KE; Bradshaw E; Tonc E; Verbaro DJ; Kometani K; Yokoyama WM; Kurosaki T; Satpathy AT; Egawa T
    J Immunol; 2021 Jun; 206(12):2924-2936. PubMed ID: 34088768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.